NTC Pharma - About the company
NTC Pharma is an acquired company based in Milan (Italy), founded in 2002. It operates as a Developer of pharmaceutical products for ophthalmology, gastroenterology, and gynecology. The company has 1239 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Teva Pharmaceuticals and Wockhardt.
Company Details
Developer of pharmaceutical products for ophthalmology, gastroenterology, and gynecology. It focuses on research, development, registration, and commercialization of drugs, medical devices, and food supplements. The company's research aims to create innovative therapeutic solutions that improve patient care. A significant portion of its portfolio is dedicated to ophthalmology, with additional offerings in gastro-metabolism and gynecology, as well as pediatrics. It employs a business-to-business model alongside direct commercial activities in select markets.
- Website
- ntcpharma.com
- Phone Number
- +39 **********
Key Metrics
Founded Year
2002
Location
Milan, Italy
Stage
Acquired
Ranked
66th among 1239 active competitors
Employee Count
135 as on Sep 30, 2026
Similar Companies
Exit Details
Acquired by Wise Equity (Mar 30, 2015)
NTC Pharma's acquisition details
NTC Pharma got acquired by Wise Equity on Mar 30, 2015.
Click here to take a look at NTC Pharma's acquisition in detail
Sign up to download NTC Pharma's company profile
NTC Pharma's funding and investors
NTC Pharma has not raised any funding rounds yet.
NTC Pharma's founders and board of directors
Founder? Claim ProfileNTC Pharma's employee count trend
NTC Pharma has 135 employees as of Sep 26. Here is NTC Pharma's employee count trend over the years:
Uncover NTC Pharma's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NTC Pharma's Competitors and alternates
Top competitors of NTC Pharma include Bayer, Teva Pharmaceuticals and Wockhardt. Here is the list of Top 10 competitors of NTC Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd |  Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public | Traditional company engaged in manufacturing generics | $500M | 75/100 | |
3rd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 71/100 | ||
4th |  Biological E 1953, Hyderabad (India), Funding Raised | Developer of vaccines for treating multiple diseases | - | 69/100 | |
5th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
6th | The Alvogen 2009, Morristown (United States), Acquired | Developer and marketer of pharmaceutical products | $156M | 69/100 | |
7th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
8th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
9th | Laboratorio Reig Jofre 2000, Barcelona (Spain), Public | Manufacturer of pharmaceutical products and food supplements | - | 68/100 | |
10th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 | |
66th | NTC Pharma 2002, Milan (Italy), Acquired | Developer of pharmaceutical products for ophthalmology, gastroenterology, and gynecology | - | - | 56/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on NTC Pharma's competitors? Click here to see the top ones
NTC Pharma's Investments and acquisitions
NTC Pharma has made no investments or acquisitions yet.
News related to NTC Pharma
Filter this listMedia has covered NTC Pharma for a total of 2 events in the last 1 year.
•
NTC, backed by Wise Equity, completes acquisition of Pharmathen USA's ophthalmology businessPR Newswire•Dec 10, 2025•Pharmathen, NTC Pharma
•
NTC renews its collaboration with Sightsavers ItaliaEuropa Press•Sep 30, 2025•Sightsavers, NTC Pharma
•
NTC study confirms safety of fixed-dose eye drops for post-cataract surgeryCNW•Jul 17, 2025•NTC Pharma
•
NTC presents positive success of the phase II Mirakle study for bacterial conjunctivitisPR Newswire•Dec 05, 2024•NTC Pharma
•
NTC Launches Imperial, the new eye drops product line on THE PATIENT'S SIDECNW•Oct 07, 2024•NTC Pharma
•
NTC gives long -term consistency to its ophthalmology portfolio with another approval of the CE MDR certificatePR Newswire•May 30, 2024•NTC Pharma
•
NTC ensures the sustainability of its portfolio of ophthalmological products by obtaining a new MDR CE certificatePR Newswire•May 30, 2024•NTC Pharma
•
NTC strengthens digital interaction with its customers with Multichannel Veeva CRMPR Newswire•Feb 16, 2022•NTC Pharma, Veeva Systems
•
NTC and I-MED Pharma Form Partnership to Bring HA-Based Dry Eye Ointment to U.S. MarketVision Monday•Dec 28, 2021•NTC Pharma, I-MED Pharma
•
NTC and STADA Announce Commercial Partnership For Portfolio Of Ophthalmic Products In The Mena RegionPR Newswire•Sep 07, 2021•Stada, NTC, NTC Pharma
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about NTC Pharma
Explore our recently published companies
- Wellokpharma - India based, Unfunded company
- Kremers Urban Pharmaceuticals - Seymour based, 1904 founded, Acquired company
- Pendopharm - Montreal based, 1983 founded, Unfunded company
- Alisons - Unfunded company
- Medrain Pharmaceuticals - Kolkata based, 2017 founded, Deadpooled company
- Kimia Farma - Jakarta based, 1817 founded, Public company
